Home Life Sciences Splice Variants of Human Cathepsin L mRNA Show Different Expression Rates
Article
Licensed
Unlicensed Requires Authentication

Splice Variants of Human Cathepsin L mRNA Show Different Expression Rates

  • Abulizi Abudula , Winfried Rommerskirch , Ekkehard Weber , Dagmar Günther and Bernd Wiederanders
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 382 Issue 11

Abstract

Human cathepsin L (hCATL) mRNA occurs in vivo in at least three splice variants. They differ in the length of exon 1, which comprises 278 nucleotides (hCATLA), 188 nucleotides (hCATLA2) and 132 nucleotides (hCATLA3), respectively. We describe here the shortest variant for the first time. This form is predominant in all tissues and cells examined so far, including malignant tumors. We studied the expression rate of the three mRNA variants in order to explain why malignant kidney tumors show low cathepsin L activity despite of high mRNA levels. The variant hCATLA3 showed the highest expression rate in vitro and in vivo. Based on these results, we suggest a cisacting element on human cathepsin L mRNA which can be bound by a negative transacting regulator, thus leading to reduced expression rates.

:
Published Online: 2005-06-01
Published in Print: 2001-11-13

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Downloaded on 9.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2001.193/html
Scroll to top button